In addition, CTGF/CCN2 was proven to have an oncogenic role in HCC; it contributes to tumor-stromal crosstalk [46], and promotes tumor cell growth, dedifferentiation, resistance to doxorubicin, and expression of inflammation-related proteins that contribute to carcinogenesis [47]. The gene discussed is CCN2; the disease is neoplasm.